Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Cash Flows from Operating Activities:
Net Income	$ 3,399	$ 3,585
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	810	1,049
Provision for bad debts	500	485
Stock issued for costs and expenses	0	220
Compensatory element of stock issuances	147	34
(Increase) decrease in operating assets, net:
Accounts, management fee and medical receivable(s)	(1,773)	(68)
Notes receivable	67	42
Costs and estimated earnings in excess of Billings on uncompleted contracts	382	(983)
Inventories	(44)	(1,406)
Prepaid expenses and other current assets	(44)	82
Other assets	(23)	37
Increase (decrease) in operating liabilities, net:
Accounts payable	(94)	(189)
Other current liabilities	602	(312)
Customer advances	257	(943)
Billings in excess of costs and estimated earnings on uncompleted contracts	0	732
Other liabilities	(22)	(8)
Due to related medical practices	1	1
Income tax payable	(100)	(75)
Net cash provided by operating activities	4,065	2,283
Cash Flows from Investing Activities:
Purchases of property and equipment	(276)	(380)
Cost of patents	(62)	(75)
Net cash (used in) provided by investing activities	(338)	(455)
Cash Flows from Financing Activities:
Repayment of borrowings and capital lease obligations	(514)	(646)
Distributions to non controlling interests	(497)	(563)
Repayment of notes receivable from employee stockholders	12	41
Net cash used in financing activities	(999)	(1,168)
Net Increase in Cash and Cash Equivalents	2,728	660
Cash and Cash Equivalents - Beginning of Period	12,032	9,251
Cash and Cash Equivalents - End of Period	$ 14,760	$ 9,911